FIELD: medicine. SUBSTANCE: this solid medicinal form designed for oral application in the form of capsules containing iphosphamide as active substance and microcrystalline cellulose or tablets containing about 0.04 to 0.4 percent by mass tricalciumphosphate taken per one part by mass (0.1 to 1.0) iphosphamide and 5 to 60 percent by mass of filler (per mass of single tablet), about 1.0 to 10.0 mass percent fluidity-control additive, 0.1 to 10.0 mass percent additive carrier capable of producing antisclerotic effect, and 0.1 to 80.0 mass percent of binder. EFFECT: more sophisticated medicinal preparation.
